Literature DB >> 30625326

Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope.

Xishan Lu1, Haixia Xiao1, Shihua Li2, Xuefei Pang1, Jian Song2, Sheng Liu2, Huijun Cheng3, Yan Li2, Xiangxi Wang4, Chaobin Huang1, Tianling Guo1, Jan Ter Meulen5, Stephane Daffis5, Jinghua Yan6, Lianpan Dai3, Zihe Rao4, Hans-Dieter Klenk5, Jianxun Qi2, Yi Shi2, George F Gao7.   

Abstract

Yellow fever virus (YFV), a deadly human pathogen, is the prototype of the genus Flavivirus. Recently, YFV re-emerged in Africa and Brazil, leading to hundreds of deaths, with some cases imported to China. Prophylactic or therapeutic countermeasures are urgently needed. Previously, several human monoclonal antibodies against YFV were screened out by phage display. Here, we find that one of them, 5A, exhibits high neutralizing potency and good protection. Crystallographic analysis of the YFV envelope (E) protein in its pre- and post-fusion states shows conformations similar to those observed in other E proteins of flaviviruses. Furthermore, the structures of 5A in complex with the E protein in both states are resolved, revealing an invariant recognition site. Structural analysis and functional data suggest that 5A has high neutralization potency because it interferes with virus entry by preventing both virus attachment and fusion. These findings will be instrumental for immunogen or inhibitor design.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  crystal structure; envelope protein; epitope; flavivirus; neutralizing monoclonal antibody; postfusion; prefusion; yellow fever virus

Mesh:

Substances:

Year:  2019        PMID: 30625326     DOI: 10.1016/j.celrep.2018.12.065

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  15 in total

1.  Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.

Authors:  Xu Yang; Jianxun Qi; Ruchao Peng; Lianpan Dai; Ernest A Gould; George F Gao; Po Tien
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 2.  Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever.

Authors:  Amanda Makha Bifani; Eugenia Z Ong; Ruklanthi de Alwis
Journal:  Curr Treat Options Infect Dis       Date:  2020-07-10

Review 3.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

4.  Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.

Authors:  Michael P Doyle; Joseph R Genualdi; Adam L Bailey; Nurgun Kose; Christopher Gainza; Jessica Rodriguez; Kristen M Reeder; Christopher A Nelson; Prashant N Jethva; Rachel E Sutton; Robin G Bombardi; Michael L Gross; Justin G Julander; Daved H Fremont; Michael S Diamond; James E Crowe
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

5.  Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes.

Authors:  Leike Li; Weixu Meng; Melanie Horton; Daniel R DiStefano; Elizabeth A Thoryk; Jennifer M Pfaff; Qihui Wang; Georgina T Salazar; Trevor Barnes; Benjamin J Doranz; Andrew J Bett; Danilo R Casimiro; Kalpit A Vora; Zhiqiang An; Ningyan Zhang
Journal:  PLoS Pathog       Date:  2019-06-06       Impact factor: 6.823

6.  Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine.

Authors:  Anna Z Wec; Denise Haslwanter; Yasmina N Abdiche; Laila Shehata; Nuria Pedreño-Lopez; Crystal L Moyer; Zachary A Bornholdt; Asparouh Lilov; Juergen H Nett; Rohit K Jangra; Michael Brown; David I Watkins; Clas Ahlm; Mattias N Forsell; Félix A Rey; Giovanna Barba-Spaeth; Kartik Chandran; Laura M Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-09       Impact factor: 11.205

Review 7.  Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus.

Authors:  Robin D V Kleinert; Eduardo Montoya-Diaz; Tanvi Khera; Kathrin Welsch; Birthe Tegtmeyer; Sebastian Hoehl; Sandra Ciesek; Richard J P Brown
Journal:  Viruses       Date:  2019-10-17       Impact factor: 5.048

Review 8.  Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever.

Authors:  Amanda Makha Bifani; Eugenia Z Ong; Ruklanthi de Alwis
Journal:  Curr Treat Options Infect Dis       Date:  2020-11-06

9.  Generation of a reporter yellow fever virus for high throughput antiviral assays.

Authors:  Ricardo Sanchez-Velazquez; Giuditta de Lorenzo; Rapeepat Tandavanitj; Chayanee Setthapramote; Peter J Bredenbeek; Leonia Bozzacco; Margaret R MacDonald; Jordan J Clark; Charles M Rice; Arvind H Patel; Alain Kohl; Margus Varjak
Journal:  Antiviral Res       Date:  2020-09-24       Impact factor: 5.970

10.  Extensive flavivirus E trimer breathing accompanies stem zippering of the post-fusion hairpin.

Authors:  Iris Medits; Marie-Christine Vaney; Alexander Rouvinski; Martial Rey; Julia Chamot-Rooke; Felix A Rey; Franz X Heinz; Karin Stiasny
Journal:  EMBO Rep       Date:  2020-06-02       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.